Patent details
EP2361617 Title: Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies
Basic Information
- Publication number:
- EP2361617
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP111614731
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies
- French Title of Invention:
- Implants intra-oculaires à libération prolongée comprenant un antagoniste du récepteur bêta-adrénergique et procédés pour le traitement de neuropathies
- German Title of Invention:
- Intraokulare Implantate mit verzögerter Freigabe mit einem beta-adregenischen Rezeptorantagonisten und Verfahren zur Behandlung okularer Neuropathien
- SPC Number:
Dates
- Filing date:
- 21/04/2005
- Grant date:
- 11/06/2014
- EP Publication Date:
- 11/06/2014
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 31/08/2011
- EP B1 Publication Date:
- 11/06/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 21/04/2015
- Expiration date:
- 21/04/2025
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 21/04/2005
- Name:
- ALLERGAN INC.
- Address:
- 2525 Dupont Drive, Irvine CA 92612, United States (US)
Inventor
1
- Name:
- Huang Glenn T.
- Address:
- United States (US)
2
- Name:
- Nivaggioli Thierry
- Address:
- United States (US)
Priority
- Priority Number:
- 836880
- Priority Date:
- 30/04/2004
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 9/70;
| Filing date | Document type | Number of pages |
|---|